Fig. 5

Estimated overall survival (OS) (a) and progression-free survival (PFS) (b) for the whole cohort of patients using proposed microscopic score including four prognostic microscopic features (adrenal capsular invasion, venous invasion, confluent necrosis, mitotic count > 15/20 high-power fields) and Ki67 labeling index ≥ 15%